New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 26, 2012
15:24 EDTCERE, SYTCeres' Syngenta collaboration an endorsement of technology, says Raymond James
Raymond James said Ceres' (CERE) collaboration with Syngenta (SYT) is an endorsement of its technology and supports rising adoption of sweet sorghum by Brazilian mill owners. Shares of Ceres are Outperform rated.
News For CERE;SYT From The Last 14 Days
Check below for free stories on CERE;SYT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2013
14:56 EDTSYTInsecticide sales robust as genetic modifications lose benefit, WSJ says
Insecticide sales are ramping up strongly as American farmers plant more corn and a genetic modification designed to protect the crop from pests has begun to lose its effectiveness against pests, says the Wall Street Journal. Reference Link
May 14, 2013
06:12 EDTSYTSyngenta and DuPont announce technology license agreement
Syngenta (SYT) and DuPont (DD) announced technology licensing agreements that will broaden each company's crop protection product portfolio and enable both to bring new products to market more efficiently. Syngenta has obtained a global license from DuPont to develop products containing DuPont's fungicide oxathiapiprolin. Under the agreements, Syngenta receives exclusive rights for foliar and soil uses on all crops in North America and for lawn and garden uses globally. Syngenta also secures rights on certain crops for seed treatment globally and for the development of foliar and soil uses on certain crops outside of North America. The agreement gives DuPont exclusive access to Syngenta's Solatenol for mixture with DuPont's picoxystrobin fungicide on soybean and other crops in Brazil. Solatenol is a new benz-pyrazole SDHI fungicide which brings a new mode of action with no cross-resistance to existing fungicides. It offers outstanding and long-lasting control of Asian rust in soybean.

Sign up for a free trial to see the rest of the stories you've been missing.